Annual Net Income
-$214.53 M
-$50.61 M-30.88%
December 31, 2023
Summary
- As of February 22, 2025, CRNX annual net profit is -$214.53 million, with the most recent change of -$50.61 million (-30.88%) on December 31, 2023.
- During the last 3 years, CRNX annual net income has fallen by -$140.72 million (-190.64%).
- CRNX annual net income is now -3464.20% below its all-time high of -$6.02 million, reached on December 31, 2016.
Performance
CRNX Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$76.83 M
-$2.77 M-3.74%
September 30, 2024
Summary
- As of February 22, 2025, CRNX quarterly net profit is -$76.83 million, with the most recent change of -$2.77 million (-3.74%) on September 30, 2024.
- Over the past year, CRNX quarterly net income has dropped by -$19.37 million (-33.71%).
- CRNX quarterly net income is now -4561.89% below its all-time high of -$1.65 million, reached on June 30, 2017.
Performance
CRNX Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$277.91 M
-$19.37 M-7.49%
September 30, 2024
Summary
- As of February 22, 2025, CRNX TTM net profit is -$277.91 million, with the most recent change of -$19.37 million (-7.49%) on September 30, 2024.
- Over the past year, CRNX TTM net income has dropped by -$78.49 million (-39.36%).
- CRNX TTM net income is now -10564.24% below its all-time high of -$2.61 million, reached on March 31, 2017.
Performance
CRNX TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
CRNX Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -30.9% | -33.7% | -39.4% |
| 3 y3 years | -190.6% | -33.7% | -39.4% |
| 5 y5 years | -691.2% | -33.7% | -39.4% |
CRNX Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -99.3% | at low | -149.5% | at low | -158.2% | at low |
| 5 y | 5-year | -325.5% | at low | -428.1% | at low | -451.2% | at low |
| alltime | all time | -3464.2% | at low | -4561.9% | at low | <-9999.0% | at low |
Crinetics Pharmaceuticals Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$76.83 M(+3.7%) | -$277.91 M(+7.5%) |
| Jun 2024 | - | -$74.06 M(+10.6%) | -$258.54 M(+9.8%) |
| Mar 2024 | - | -$66.93 M(+11.4%) | -$235.46 M(+9.8%) |
| Dec 2023 | -$214.53 M(+30.9%) | -$60.10 M(+4.6%) | -$214.53 M(+7.6%) |
| Sep 2023 | - | -$57.46 M(+12.7%) | -$199.42 M(+8.4%) |
| Jun 2023 | - | -$50.98 M(+10.8%) | -$183.89 M(+4.9%) |
| Mar 2023 | - | -$45.99 M(+2.2%) | -$175.29 M(+6.9%) |
| Dec 2022 | -$163.92 M(+52.3%) | -$44.99 M(+7.3%) | -$163.92 M(+9.5%) |
| Sep 2022 | - | -$41.92 M(-1.1%) | -$149.72 M(+10.4%) |
| Jun 2022 | - | -$42.38 M(+22.4%) | -$135.65 M(+13.6%) |
| Mar 2022 | - | -$34.63 M(+12.4%) | -$119.37 M(+10.9%) |
| Dec 2021 | -$107.64 M(+45.8%) | -$30.79 M(+10.6%) | -$107.64 M(+9.3%) |
| Sep 2021 | - | -$27.85 M(+6.7%) | -$98.49 M(+10.7%) |
| Jun 2021 | - | -$26.09 M(+13.9%) | -$88.96 M(+12.1%) |
| Mar 2021 | - | -$22.90 M(+5.8%) | -$79.35 M(+7.5%) |
| Dec 2020 | -$73.81 M | -$21.64 M(+18.1%) | -$73.81 M(+10.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | -$18.32 M(+11.1%) | -$66.72 M(+6.2%) |
| Jun 2020 | - | -$16.49 M(-5.0%) | -$62.83 M(+6.9%) |
| Mar 2020 | - | -$17.36 M(+19.3%) | -$58.77 M(+16.5%) |
| Dec 2019 | -$50.42 M(+86.0%) | -$14.55 M(+0.8%) | -$50.42 M(+13.6%) |
| Sep 2019 | - | -$14.43 M(+16.1%) | -$44.37 M(+18.2%) |
| Jun 2019 | - | -$12.43 M(+37.8%) | -$37.53 M(+22.4%) |
| Mar 2019 | - | -$9.02 M(+6.1%) | -$30.67 M(+13.1%) |
| Dec 2018 | -$27.11 M(+196.1%) | -$8.49 M(+12.0%) | -$27.11 M(+28.3%) |
| Sep 2018 | - | -$7.59 M(+36.3%) | -$21.14 M(+32.7%) |
| Jun 2018 | - | -$5.57 M(+1.9%) | -$15.94 M(+32.6%) |
| Mar 2018 | - | -$5.46 M(+116.7%) | -$12.02 M(+31.2%) |
| Dec 2017 | -$9.16 M(+52.1%) | -$2.52 M(+5.8%) | -$9.16 M(+38.0%) |
| Sep 2017 | - | -$2.38 M(+44.5%) | -$6.64 M(+56.0%) |
| Jun 2017 | - | -$1.65 M(-36.8%) | -$4.25 M(+63.2%) |
| Mar 2017 | - | -$2.61 M | -$2.61 M |
| Dec 2016 | -$6.02 M | - | - |
FAQ
- What is Crinetics Pharmaceuticals annual net profit?
- What is the all time high annual net income for Crinetics Pharmaceuticals?
- What is Crinetics Pharmaceuticals annual net income year-on-year change?
- What is Crinetics Pharmaceuticals quarterly net profit?
- What is the all time high quarterly net income for Crinetics Pharmaceuticals?
- What is Crinetics Pharmaceuticals quarterly net income year-on-year change?
- What is Crinetics Pharmaceuticals TTM net profit?
- What is the all time high TTM net income for Crinetics Pharmaceuticals?
- What is Crinetics Pharmaceuticals TTM net income year-on-year change?
What is Crinetics Pharmaceuticals annual net profit?
The current annual net income of CRNX is -$214.53 M
What is the all time high annual net income for Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals all-time high annual net profit is -$6.02 M
What is Crinetics Pharmaceuticals annual net income year-on-year change?
Over the past year, CRNX annual net profit has changed by -$50.61 M (-30.88%)
What is Crinetics Pharmaceuticals quarterly net profit?
The current quarterly net income of CRNX is -$76.83 M
What is the all time high quarterly net income for Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals all-time high quarterly net profit is -$1.65 M
What is Crinetics Pharmaceuticals quarterly net income year-on-year change?
Over the past year, CRNX quarterly net profit has changed by -$19.37 M (-33.71%)
What is Crinetics Pharmaceuticals TTM net profit?
The current TTM net income of CRNX is -$277.91 M
What is the all time high TTM net income for Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals all-time high TTM net profit is -$2.61 M
What is Crinetics Pharmaceuticals TTM net income year-on-year change?
Over the past year, CRNX TTM net profit has changed by -$78.49 M (-39.36%)